Cargando…

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer

In the last decade, better understanding of the role of epidermal growth factor receptor in the pathogenesis and progression of non-small cell lung cancer has led to a revolution in the work-up of these neoplasms. Tyrosine kinase inhibitors, such as erlotinib and gefitinib, have been approved for th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berardi, Rossana, Santoni, Matteo, Morgese, Francesca, Ballatore, Zelmira, Savini, Agnese, Onofri, Azzurra, Mazzanti, Paola, Pistelli, Mirco, Pierantoni, Chiara, De Lisa, Mariagrazia, Caramanti, Miriam, Pagliaretta, Silvia, Pellei, Chiara, Cascinu, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665567/ https://www.ncbi.nlm.nih.gov/pubmed/23723712 http://dx.doi.org/10.2147/OTT.S28155

Ejemplares similares

Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
por: Berardi, Rossana, et al.
Publicado: (2016)

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
por: Berardi, Rossana, et al.
Publicado: (2016)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
por: Pistelli, Mirco, et al.
Publicado: (2015)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
por: Pistelli, Mirco, et al.
Publicado: (2014)

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2017)

The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions
por: Berardi, Rossana, et al.
Publicado: (2020)

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Correction to: Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type
por: Maccaroni, Elena, et al.
Publicado: (2021)

Gender differences and outcome of melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2015)

Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options
por: Scartozzi, M, et al.
Publicado: (2007)

Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report
por: Ballatore, Z., et al.
Publicado: (2016)

The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy
por: Bittoni, Alessandro, et al.
Publicado: (2014)

Gender Differences and Outcomes in Melanoma Patients
por: Morgese, Francesca, et al.
Publicado: (2020)

A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018)

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
por: Moroncini, Gianluca, et al.
Publicado: (2018)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
por: Agostinelli, Veronica, et al.
Publicado: (2023)

Non-small-cell lung cancer: how to manage EGFR-mutated disease
por: Pecci, Federica, et al.
Publicado: (2022)

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis
por: Scartozzi, Mario, et al.
Publicado: (2009)

Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
por: Giampieri, Riccardo, et al.
Publicado: (2019)

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study
por: Berardi, Rossana, et al.
Publicado: (2020)

Systemic treatment for lung carcinoids: from bench to bedside
por: Torniai, Mariangela, et al.
Publicado: (2019)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review
por: Cognigni, Valeria, et al.
Publicado: (2021)

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
por: Santoni, Matteo, et al.
Publicado: (2014)

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
por: Scartozzi, Mario, et al.
Publicado: (2010)

Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine
por: Ballatore, Zelmira, et al.
Publicado: (2023)

The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives
por: Cognigni, Valeria, et al.
Publicado: (2022)

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
por: Galvez‐Nino, Marco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hl988l1u21fmtpf5vb4ueuars4